Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Crescendo Biologics Ltd

Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumours
From Crescendo Biologics Ltd
Via Business Wire
Crescendo Biologics Announces That Zai Lab Has Achieved Proof-of-Concept for ZL-1102 (Humabody®, CB001) in a Phase 1b Clinical Trial in Psoriasis Patients
From Crescendo Biologics Ltd
Via Business Wire
Tickers ZLAB
Crescendo Biologics Announces Prestigious New Collaboration With the Institute of Cancer Research, London
From Crescendo Biologics Ltd
Via Business Wire
Crescendo to Participate in Upcoming Investor Conferences
From Crescendo Biologics Ltd
Via Business Wire
Crescendo to Participate in Upcoming Investor Events
From Crescendo Biologics Ltd
Via Business Wire
Crescendo to participate in upcoming investor conferences
From Crescendo Biologics Ltd
Via Business Wire
Crescendo to Participate in Upcoming Investor Conferences
From Crescendo Biologics Ltd
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.